Director
Professor of Internal Medicine (Medical Oncology & Hematology); Director, Precision Medicine, Yale Cancer Center and Smilow Cancer Hospital; Service Line Medical Director, Smilow Cancer Hospital at Greenwich Hospital
Precision cancer medicine is an approach that tailors treatment to the unique genetic, molecular, and clinical features of each patient and their disease, enabling more targeted and personalized therapeutic strategies aimed at maximizing efficacy and minimizing toxicity.
Cancer is highly heterogeneous, or diverse; one-size-fits-all treatments are insufficient.
To lead globally as an academic health system advancing precision medicine in cancer care, continuously evolving through integration of science, technology, and clinical trials; promoting collaboration, differences in populations and ethical data stewardship; delivering real-world clinical impact; and shaping a lasting impact through education.
The board serves as a central forum for multidisciplinary dialogue, education, and the integration of molecular diagnostics into patient care at Yale Cancer Center. The tumor board meets twice monthly on alternating Fridays, from noon to 1 p.m., with each one-hour session held in a hybrid format. While virtual participation is available, in-person attendance is strongly encouraged to foster collaboration and physical interaction. Lunch is provided onsite. Check the calendar for details.
Director
Professor of Internal Medicine (Medical Oncology & Hematology); Director, Precision Medicine, Yale Cancer Center and Smilow Cancer Hospital; Service Line Medical Director, Smilow Cancer Hospital at Greenwich Hospital
Associate Director
Research Scientist; Associate Director, Precision Medicine, Yale Cancer Center and Smilow Cancer Hospital; Director for Education and Translational Research, Medical Oncology and Hematology; Associate Program Director, Master of Health Science in Clinical Investigation (MHS-CI)